Sign Out
LEQEMBI is indicated for slowing the progression of Alzheimer's disease in patients with mild cognitive impairment or mild dementia stage of disease.
The safety and efficacy of lecanemab have not been established in patients with moderate or severe Alzheimer's disease.
Continue with Google